ArticlePloS one2026
Contraceptive uptake and characteristics in the immediate postpartum period among women attending Tygerberg Academic Hospital.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The immediate postpartum period is a unique opportunity to motivate and educate women on family planning options. This study aimed to determine the prevalence of family planning use in our setting. Secondary objectives include determining the frequency of the various methods used, the safety of the method(s), common risk factors, the interval spacing between births and associations with family planning method choices. A cross-sectional study was conducted at Tygerberg Academic Hospital, South Africa, which serves a predominantly low socioeconomic status and high-risk obstetric population. Medical records were assessed prospectively from January 2023 till July 2023. Data was collected and captured from maternity medical records on the day of discharge. The statistical analysis was done using frequencies and percentages, with 95% confidence intervals (95%CI). A secondary bivariant analysis was done to evaluate the associations between these variables. Of the 1066 participants included, 97.5% (95%CI 96.5-98.5) received family planning. The majority of the patients (48.8%) requested the injectable depo medroxyprogesterone acetate. These patients who chose this method were on average younger (OR 0.962, p < 0.001), had a lower BMI (OR 0.983, p = 0.012), and were a higher parity (OR 0.721, p < 0.001). HIV positive women were also 35% less likely (OR 0.651, p = 0.008) to choose this method compared to other methods. Of the 1039 patients who had received family planning, 47.8% were classified into a World Health Organization medical eligibility category three. This was almost exclusively attributed due to patients who were breastfeeding and requested the depo medroxyprogesterone acetate as their family planning method postpartum. The majority (66%) of the patients had spaced their pregnancies more than two years apart. The exceptionally high prevalence of uptake of family planning indicates it can be successfully implemented in the postpartum period. Patients should be counselled individually on the safest and the most appropriate method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.